Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - NEXUS BIOPHARMA INC | f10q0517ex31-1_nexusbiohtm.htm |
| 10-Q - QUARTERLY REPORT - NEXUS BIOPHARMA INC | f10q0517_nexusbiopharma.htm |
EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Warren Lau, the Chief Executive Officer and Chief Financial Officer of Nexus BioPharma, Inc. (the “Company”), hereby certify, that, to my knowledge:
1. The Quarterly Report on Form 10-Q for the quarter ended May 31, 2017 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: October 27, 2017 | /s/ Warren Lau |
| Warren Lau | |
| Chief Executive Officer (Principal Executive Officer) | |
| Chief Financial Officer (Principal Financial and Accounting Officer) |